先进制造业知识服务平台
国家科技图书文献中心机械分馆  工信部产业技术基础公共服务平台  国家中小企业公共服务示范平台

OA期刊


ISSN1942-0862
刊名Mabs
出版商Taylor & Francis Inc.
urlhttps://www.tandfonline.com/loi/kmab20
机构Taylor & Francis Ltd.



全部

2010 2011 2012 2013 2014 2015
2016 2017 2018 2019 2020 2021
2022 2023 2024 2025

2024, vol.16, no.1 2024, vol.16, no.10 2024, vol.16, no.11 2024, vol.16, no.12 2024, vol.16, no.2 2024, vol.16, no.3
2024, vol.16, no.4 2024, vol.16, no.5 2024, vol.16, no.6 2024, vol.16, no.7 2024, vol.16, no.8 2024, vol.16, no.9

题名作者出版年年卷期
A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapyGerhard Frey;Ana Paula G. Cugnetti;Haizhen Liu;Charles Xing;Christina Wheeler;Hwai Wen Chang;William J. Boyle;Jay M. Short;20242024, vol.16, no.3
Improving the integrity and reproducibility of research that uses antibodies: a technical, data sharing, behavioral and policy challengeM. Biddle;P. Stylianou;M. Rekas;A. Wright;J. Sousa;D. Ruddy;M. I. Stefana;K. Kmiecik;A. Bandrowski;R.A. Kahn;C. Laflamme;E. M. Krockow;H.S. Virk;20242024, vol.16, no.3
Exploring molecular determinants and pharmacokinetic properties of IgG1-scFv bispecific antibodiesKristina M.J. Aertker;Minu Ravindra Pilvankar;Tobias M. Prass;Michaela Blech;Fabian Higel;Srinath Kasturirangan;20242024, vol.16, no.3
Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometryJing Xu;John E. Coughlin;Malgorzata Szyjka;Serene Jabary;Sonal Saluja;Zoran Sosic;Yunqiu Chen;Chong-Feng Xu;20242024, vol.16, no.3
Biparatopic antibodies: therapeutic applications and prospectsDavid L. Niquille;Kyle M. Fitzgerald;Nimish Gera;20242024, vol.16, no.3
In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodiesAimee E. Mattei;Andres H. Gutierrez;Soorya Seshadri;Jacob Tivin;Matt Ardito;Amy S. Rosenberg;William D. Martin;Anne S. De Groot;20242024, vol.16, no.3
Predicting deamidation and isomerization sites in therapeutic antibodies using structure-based in silico approachesDavid Hoffmann;Joschka Bauer;Markus Kossner;Andrew Henry;Anne R. Karow-Zwick;Giuseppe Licari;20242024, vol.16, no.3
RUBY® – a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability propertiesBarnabas Nyesiga;Mattias Levin;Anna Säll;Anna Rosén;Kim Jansson;Sara Fritzell;Karin Hägerbrand;Dietmar Weilguny;Laura von Schantz;20242024, vol.16, no.3
Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfacesW. van der Wulp;W. Luu;M. E. Ressing;J. Schuurman;S. I. van Kasteren;L. Guelen;R. C. Hoeben;B. Bleijlevens;M. H. M. Heemskerk;20242024, vol.16, no.3
T and B cell epitope analysis for the immunogenicity evaluation and mitigation of antibody-based therapeuticsRuoxuan Sun;Mark G. Qian;Xiaobin Zhang;20242024, vol.16, no.3
12